Propofol 2%: understanding a new concentration of a well-known medication

Betsy A Regier^{1

2}, Tricia A Meyer^{2

3}, Russell K McAllister^{1

2}

Affiliations

¹ Department of Anesthesiology, Baylor Scott & White Medical Center - Temple, Temple, Texas.
² Department of Anesthesiology, Texas A&M College of Medicine, Temple, Texas.
³ Department of Pharmacy, Baylor Scott & White Medical Center - Temple, Temple, Texas.

Betsy A Regier et al. Proc (Bayl Univ Med Cent). 2021.

. 2021 Jun 17;34(5):642-643.

doi: 10.1080/08998280.2021.1937009. eCollection 2021 Sep.

Betsy A Regier^{1

2}, Tricia A Meyer^{2

3}, Russell K McAllister^{1

2}

¹ Department of Anesthesiology, Baylor Scott & White Medical Center - Temple, Temple, Texas.
² Department of Anesthesiology, Texas A&M College of Medicine, Temple, Texas.
³ Department of Pharmacy, Baylor Scott & White Medical Center - Temple, Temple, Texas.

No abstract available

Cited by

Safety of Extended Propofol Infusions in Critically Ill Pediatric Patients.
Moas D, Aydin EY, Irazuzta J, Filipp S, Guthrie KK, Manasco K, Pringle C. Moas D, et al. Cureus. 2024 May 9;16(5):e59948. doi: 10.7759/cureus.59948. eCollection 2024 May. Cureus. 2024. PMID: 38854299 Free PMC article.

1. Erden IA, Gülmez D, Pamuk AG, Akincia SB, Hasçelik G, Aypar U.. The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not. Braz J Anesthesiol. 2013;63(6):466–472. doi:10.1016/j.bjane.2012.10.003. - DOI - PubMed
1. US Food and Drug Administration . Propoven 2% fact sheet for health care providers. https://www.fda.gov/media/137889/download. Accessed May 15, 2021.
1. Sato K, Kamii H, Kato M.. Effect of 1% and 2% propofol in MCT/LCT emulsion on serum lipids. J Neurosurg Anesthesiol. 2006;18(4):301.
1. Barrientos-Vega R, Sánchez-Soria MM, Morales-Garcia C, Cuena-Boy R, Castellano-Hernández M.. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med. 2001;29(2):317–322. doi:10.1097/00003246-200102000-00018. - DOI - PubMed
1. Truitt E, Thompson R, Blazey-Martin D, NiSai D, Salem D.. Effect of the implementation of barcode technology and an electronic medication administration record on adverse drug events. Hosp Pharm. 2016;51(6):474–483. doi:10.1310/hpj5106-474. - DOI - PMC - PubMed